SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Phase 3 Trial Finds Chemotherapy-Free Treatment Improves Outcomes in dMMR Endometrial Cancer

KEYNOTE-C93/GOG-3064/ENGOT-en15 results were presented at the ESMO 2026 Presidential Symposium, according to the supplied body.

Related stories